
- /
- Supported exchanges
- / US
- / TNGNQ.OTCCE
Tengion Inc (TNGNQ OTCCE) stock market data APIs
Tengion Inc Financial Data Overview
Tengion, Inc. operates as a regenerative medicine company. The company focuses on discovering, developing, manufacturing, and commercializing a range of neo-organs or products composed of living cells with or without synthetic or natural materials that are implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. Its product portfolio includes Neo-Kidney Augment to prevent or delay dialysis by increasing renal function in patients with advanced chronic kidney disease; and Neo-Urinary Conduit, which is in Phase I clinical trial and used to replace the use of bowel tissue in bladder cancer patients requiring a non-continent urinary diversion after bladder removal surgery. The company has a license agreement with Children's Medical Center Corporation (CMCC) for the license of certain patent rights and intellectual property rights owned or controlled by CMCC related to tissue engineering technology. Tengion, Inc. was founded in 2003 and is headquartered in Winston-Salem, North Carolina. On December 29, 2014, Tengion, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Tengion Inc data using free add-ons & libraries
Get Tengion Inc Fundamental Data
Tengion Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -17 658 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-18
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tengion Inc News

Electrolux publishes 2020 Annual Report
STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Electrolux Annual Report for 2020 has been published on the Group's website as of today. The Annual Report can be downloaded in pdf format here and will be di...


Electrolux publishes 2020 Annual Report
STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Electrolux Annual Report for 2020 has been published on the Group's website as of today. The Annual Report can be downloaded in pdf format here and will be di...

Notice convening the Annual General Meeting of AB Electrolux
STOCKHOLM, Feb. 15, 2021 /PRNewswire/ -- The shareholders of AB Electrolux, reg. no. 556009-4178, are hereby given notice of the Annual General Meeting to be held on Thursday, March 25, 2021. Due to ...

Notice convening the Annual General Meeting of AB Electrolux
STOCKHOLM, Feb. 15, 2021 /PRNewswire/ -- The shareholders of AB Electrolux, reg. no. 556009-4178, are hereby given notice of the Annual General Meeting to be held on Thursday, March 25, 2021. Due to ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.